Natera 2024 J.P. Morgan Healthcare Conference Investor Presentation

Natera presents its cell-free DNA technology platform and commercialization progress across oncology, women's health, and organ health markets at the J.P. Morgan Healthcare Conference. The company has processed over 10 million tests, launched 12 products, and expanded to more than 3,200 employees with preliminary 2023 financial results included.